[1]	Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history[J]. Circulation, 1971, 43(3): 323-332. DOI: 10.1161/01.cir.43.3.323 . https://www.ncbi.nlm.nih.gov/pubmed/5102136 本文引用 [1]

[2]	Verdurmen KM, Eijsvoogel NB, Lempersz C, et al. A systematic review of prenatal screening for congenital heart disease by fetal electrocardiography[J]. Int J Gynaecol Obstet, 2016, 135(2): 129-134. DOI: 10.1016/j.ijgo.2016.05.010 . https://www.ncbi.nlm.nih.gov/pubmed/27634052 本文引用 [1]

[3]	Liu A, Diller GP, Moons P, et al. Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults[J]. Nat Rev Cardiol, 2023, 20(2): 126-137. DOI: 10.1038/s41569-022-00749-y . https://www.ncbi.nlm.nih.gov/pubmed/36045220 本文引用 [1]

[4]

Zhang Y, Wang J, Zhao J, et al. Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China[J]. Lancet Child Adolesc Health, 2023, 7(7): 479-489. DOI: 10.1016/S2352-4642(23)00051-2 . https://www.ncbi.nlm.nih.gov/pubmed/37301215 本文引用 [1]

[5]

GBD 2017 Congenital Heart Disease Collaborators. Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet Child Adolesc Health, 2020, 4(3): 185-200. PMCID: PMC7645774. DOI: 10.1016/S2352-4642(19)30402-X . https://www.ncbi.nlm.nih.gov/pubmed/31978374 本文引用 [1]

[6]	Oster ME, Lee KA, Honein MA, et al. Temporal trends in survival among infants with critical congenital heart defects[J]. Pediatrics, 2013, 131(5): e1502-e1508. PMCID: PMC4471949. DOI: 10.1542/peds.2012-3435 . https://www.ncbi.nlm.nih.gov/pubmed/23610203 本文引用 [1]

[7]	Martin GR, Schwartz BN, Hom LA, et al. Lessons learned from infants with late detection of critical congenital heart disease[J]. Pediatr Cardiol, 2022, 43(3): 580-585. DOI: 10.1007/s00246-021-02760-5 . https://www.ncbi.nlm.nih.gov/pubmed/34709442 本文引用 [1]

[8]	Eckersley L, Sadler L, Parry E, et al. Timing of diagnosis affects mortality in critical congenital heart disease[J]. Arch Dis Child, 2016, 101(6): 516-520. DOI: 10.1136/archdischild-2014-307691 . https://www.ncbi.nlm.nih.gov/pubmed/26130379 本文引用 [1]

[9]

Morris SA, Ethen MK, Penny DJ, et al. Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome[J]. Circulation, 2014, 129(3): 285-292. PMCID: PMC7302400. DOI: 10.1161/CIRCULATIONAHA.113.003711 . https://www.ncbi.nlm.nih.gov/pubmed/24135071 本文引用 [1]

[10]	World Health Organization. WHO Handbook for Guideline Development, 2nd edition[EB/OL]. (2014-12-18)[2021-02-16]. https://www.who.int/publications/i/item/9789241548960 本文引用 [1]

[11]	Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J]. Ann Intern Med, 2017, 166(2): 128-132. DOI: 10.7326/M16-1565 . https://www.ncbi.nlm.nih.gov/pubmed/27893062 本文引用 [1]

[12]	Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust[M]. Washington, DC: The National Academies Press, 2011: 57-103. 本文引用 [1]

[13]	陈耀龙. GRADE在系统评价和实践指南中的应用[M]. 2版. 北京: 中国协和医科大学出版社, 2021. 本文引用 [2]

[14]	Chu PY, Li JS, Kosinski AS, et al. Congenital heart disease in premature infants 25-32 weeks' gestational age[J]. J Pediatr, 2017, 181: 37-41.e1. PMCID: PMC5274591. DOI: 10.1016/j.jpeds.2016.10.033 . https://www.ncbi.nlm.nih.gov/pubmed/27816222 本文引用 [2]

[15]	Yokouchi-Konishi T, Yoshimatsu J, Sawada M, et al. Recurrent congenital heart diseases among neonates born to mothers with congenital heart diseases[J]. Pediatr Cardiol, 2019, 40(4): 865-870. DOI: 10.1007/s00246-019-02083-6 . https://www.ncbi.nlm.nih.gov/pubmed/30830281 本文引用 [1]

[16]	Øyen N, Poulsen G, Boyd HA, et al. Recurrence of congenital heart defects in families[J]. Circulation, 2009, 120(4): 295-301. DOI: 10.1161/CIRCULATIONAHA.109.857987 . https://www.ncbi.nlm.nih.gov/pubmed/19597048 本文引用 [1]

[17]	Brodwall K, Greve G, Leirgul E, et al. Recurrence of congenital heart defects among siblings: a nationwide study[J]. Am J Med Genet A, 2017, 173(6): 1575-1585. DOI: 10.1002/ajmg.a.38237 . https://www.ncbi.nlm.nih.gov/pubmed/28425218 本文引用 [1]

[18]	Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study[J]. Circulation, 2013, 128(6): 583-589. DOI: 10.1161/CIRCULATIONAHA.112.001054 . https://www.ncbi.nlm.nih.gov/pubmed/23812182 本文引用 [1]

[19]	Øyen N, Diaz LJ, Leirgul E, et al. Prepregnancy diabetes and offspring risk of congenital heart disease: a nationwide cohort study[J]. Circulation, 2016, 133(23): 2243-2253. PMCID: PMC4890838. DOI: 10.1161/CIRCULATIONAHA.115.017465 . https://www.ncbi.nlm.nih.gov/pubmed/27166384

[20]	Turunen R, Pulakka A, Metsälä J, et al. Maternal diabetes and overweight and congenital heart defects in offspring[J]. JAMA Netw Open, 2024, 7(1): e2350579. PMCID: PMC10770771. DOI: 10.1001/jamanetworkopen.2023.50579 . https://www.ncbi.nlm.nih.gov/pubmed/38180757 本文引用 [1]

[21]	Liu X, Ding G, Yang W, et al. Maternal body mass index and risk of congenital heart defects in infants: a dose-response meta-analysis[J]. Biomed Res Int, 2019, 2019: 1315796. PMCID: PMC6642764. DOI: 10.1155/2019/1315796 . https://www.ncbi.nlm.nih.gov/pubmed/31360700 本文引用 [1]

[22]	Persson M, Cnattingius S, Villamor E, et al. Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons[J]. BMJ, 2017, 357: j2563. PMCID: PMC5470075. DOI: 10.1136/bmj.j2563 . https://www.ncbi.nlm.nih.gov/pubmed/28615173

[23]	Persson M, Razaz N, Edstedt Bonamy AK, et al. Maternal overweight and obesity and risk of congenital heart defects[J]. J Am Coll Cardiol, 2019, 73(1): 44-53. DOI: 10.1016/j.jacc.2018.10.050 . https://www.ncbi.nlm.nih.gov/pubmed/30621950 本文引用 [1]

[24]	Zhao L, Chen L, Yang T, et al. Parental smoking and the risk of congenital heart defects in offspring: an updated meta-analysis of observational studies[J]. Eur J Prev Cardiol, 2020, 27(12): 1284-1293. DOI: 10.1177/2047487319831367 . https://www.ncbi.nlm.nih.gov/pubmed/30905164 本文引用 [1]

[25]	Zhang S, Wang L, Yang T, et al. Parental alcohol consumption and the risk of congenital heart diseases in offspring: an updated systematic review and meta-analysis[J]. Eur J Prev Cardiol, 2020, 27(4): 410-421. DOI: 10.1177/2047487319874530 . https://www.ncbi.nlm.nih.gov/pubmed/31578093 本文引用 [1]

[26]	Shamshirsaz AA, Bateni ZH, Sangi-Haghpeykar H, et al. Cyanotic congenital heart disease following fertility treatments in the United States from 2011 to 2014[J]. Heart, 2018, 104(11): 945-948. DOI: 10.1136/heartjnl-2017-312015 . https://www.ncbi.nlm.nih.gov/pubmed/29146625 本文引用 [1]

[27]	Reefhuis J, Honein MA, Schieve LA, et al. Assisted reproductive technology and major structural birth defects in the United States[J]. Hum Reprod, 2009, 24(2): 360-366. DOI: 10.1093/humrep/den387 . https://www.ncbi.nlm.nih.gov/pubmed/19010807 本文引用 [1]

[28]	Shi QY, Zhang JB, Mi YQ, et al. Congenital heart defects and maternal fever: systematic review and meta-analysis[J]. J Perinatol, 2014, 34(9): 677-682. DOI: 10.1038/jp.2014.76 . https://www.ncbi.nlm.nih.gov/pubmed/24811224 本文引用 [2]

[29]

Aranguren Bello HC, Londoño Trujillo D, Troncoso Moreno GA, et al. Oximetry and neonatal examination for the detection of critical congenital heart disease: a systematic review and meta-analysis[J]. F1000Res, 2019, 8: 242. PMCID: PMC6659768. DOI: 10.12688/f1000research.17989.1 . https://www.ncbi.nlm.nih.gov/pubmed/31372214 本文引用 [2]

[30]	陆天玮, 胡晓静, 吕天婵, 等. 新生儿危重症先天性心脏病适宜筛查窗口期和筛查地点的系统评价和Meta分析[J]. 中国循证儿科杂志, 2022, 17(4): 281-289. DOI: 10.3969/j.issn.1673-5501.2022.04.004 . 本文引用 [1]

[31]	胡晓静, 马晓静, 曾子倩, 等. 应用脉搏血氧饱和度或/和临床评估（心脏杂音听诊）筛查新生儿危重型先天性心脏病的系统评价和Meta分析[J]. 中国循证儿科杂志, 2020, 15(5): 325-332. DOI: 10.3969/j.issn.1673-5501.2020.05.002 . 本文引用 [1]

[32]	Plana MN, Zamora J, Suresh G, et al. Pulse oximetry screening for critical congenital heart defects[J]. Cochrane Database Syst Rev, 2018, 3(3): CD011912. PMCID: PMC6494396. DOI: 10.1002/14651858.CD011912.pub2 . https://www.ncbi.nlm.nih.gov/pubmed/29494750 本文引用 [1]

[33]	Searle J, Thakkar DD, Banerjee J. Does pulsatility index add value to newborn pulse oximetry screening for critical congenital heart disease?[J]. Arch Dis Child, 2019, 104(5): 504-506. DOI: 10.1136/archdischild-2018-315891 . https://www.ncbi.nlm.nih.gov/pubmed/30413491 本文引用 [1]

[34]	Zhao QM, Ma XJ, Ge XL, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study[J]. Lancet, 2014, 384(9945): 747-754. DOI: 10.1016/S0140-6736(14)60198-7 . https://www.ncbi.nlm.nih.gov/pubmed/24768155 本文引用 [2]

[35]	Lightfoot M, Hough P, Hudak A, et al. Audit of pulse oximetry screening for critical congenital heart disease (CCHD) in newborns[J]. Paediatr Child Health, 2017, 22(6): 305-306. PMCID: PMC5804783. DOI: 10.1093/pch/pxx091 . https://www.ncbi.nlm.nih.gov/pubmed/29479241 本文引用 [1]

[36]	Tsao PC, Chiang SH, Shiau YS, et al. Comparing strategies for critical congenital heart disease newborn screening[J]. Pediatrics, 2023, 151(3): e2022057862. DOI: 10.1542/peds.2022-057862 . https://www.ncbi.nlm.nih.gov/pubmed/36815269

[37]	Tsao PC, Shiau YS, Chiang SH, et al. Development of a newborn screening program for critical congenital heart disease (CCHD) in Taipei[J]. PLoS One, 2016, 11(4): e0153407. PMCID: PMC4830600. DOI: 10.1371/journal.pone.0153407 . https://www.ncbi.nlm.nih.gov/pubmed/27073996 本文引用 [1]

[38]

Almawazini AM, Hanafi HK, Madkhali HA, et al. Effectiveness of the critical congenital heart disease screening program for early diagnosis of cardiac abnormalities in newborn infants[J]. Saudi Med J, 2017, 38(10): 1019-1024. PMCID: PMC5694635. DOI: 10.15537/smj.2017.10.20295 . https://www.ncbi.nlm.nih.gov/pubmed/28917066

[39]

Ma X, Tian Y, Ma F, et al. Impact of newborn screening programme for congenital heart disease in Shanghai: a five-year observational study in 801,831 newborns[J]. Lancet Reg Health West Pac, 2023, 33: 100688. PMCID: PMC10166988. DOI: 10.1016/j.lanwpc.2023.100688 . https://www.ncbi.nlm.nih.gov/pubmed/37181527

[40]

Peterson C, Ailes E, Riehle-Colarusso T, et al. Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry[J]. JAMA Pediatr, 2014, 168(4): 361-370. PMCID: PMC4470377. DOI: 10.1001/jamapediatrics.2013.4779 . https://www.ncbi.nlm.nih.gov/pubmed/24493342

[41]	El Idrissi Slitine N, Bennaoui F, Sable CA, et al. Pulse oximetry and congenital heart disease screening: results of the first pilot study in Morocco[J]. Int J Neonatal Screen, 2020, 6(3): 53. PMCID: PMC7570348. DOI: 10.3390/ijns6030053 . https://www.ncbi.nlm.nih.gov/pubmed/33123634

[42]	Gómez-Rodríguez G, Quezada-Herrera A, Amador-Licona N, et al. Pulse oximetry as a screening test for critical congenital heart disease in term newborns[J]. Rev Invest Clin, 2015, 67(2): 130-134. DOI: 10.1016/S0034-8376(25)00232-3 . https://www.ncbi.nlm.nih.gov/pubmed/25938847

[43]	Patriciu M, Avasiloaiei A, Moscalu M, et al. Pulse oximetry during the first 24 hours as a screening tool for congenital heart defects[J]. J Crit Care Med (Targu Mures), 2017, 3(1): 12-17. PMCID: PMC5769894. DOI: 10.1515/jccm-2017-0004 . https://www.ncbi.nlm.nih.gov/pubmed/29967865

[44]	Jain D, Jain M, Lamture Y. Pulse oximetry screening for detecting critical congenital heart disease in neonates[J]. Cureus, 2022, 14(12): e32852. PMCID: PMC9870300. DOI: 10.7759/cureus.32852 . https://www.ncbi.nlm.nih.gov/pubmed/36699784 本文引用 [1]

[45]	Manja V, Mathew B, Carrion V, et al. Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit[J]. J Perinatol, 2015, 35(1): 67-71. PMCID: PMC4281287. DOI: 10.1038/jp.2014.135 . https://www.ncbi.nlm.nih.gov/pubmed/25058746 本文引用 [1]

[46]	Badawi D, Watson J, Maschke S, et al. First-year outcomes of critical congenital heart disease screening in Maryland[J]. Glob Pediatr Health, 2019, 6: 2333794X19868226. PMCID: PMC6700861. DOI: 10.1177/2333794X19868226 . https://www.ncbi.nlm.nih.gov/pubmed/31453268

[47]	Cloete E, Bloomfield FH, Cassells SA, et al. Newborn pulse oximetry screening in the context of a high antenatal detection rate of critical congenital heart disease[J]. Acta Paediatr, 2020, 109(1): 93-99. PMCID: PMC6972642. DOI: 10.1111/apa.14946 . https://www.ncbi.nlm.nih.gov/pubmed/31332832

[48]	Johnson LC, Lieberman E, O'Leary E, et al. Prenatal and newborn screening for critical congenital heart disease: findings from a nursery[J]. Pediatrics, 2014, 134(5): 916-922. DOI: 10.1542/peds.2014-1461 . https://www.ncbi.nlm.nih.gov/pubmed/25287457

[49]

Miller KK, Vig KS, Goetz EM, et al. Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the plain community[J]. J Perinatol, 2016, 36(12): 1088-1091. PMCID: PMC5130614. DOI: 10.1038/jp.2016.135 . https://www.ncbi.nlm.nih.gov/pubmed/27583398

[50]	Banait N, Ward-Platt M, Abu-Harb M, et al. Pulse oximetry screening for critical congenital heart disease: a comparative study of cohorts over 11 years[J]. J Matern Fetal Neonatal Med, 2020, 33(12): 2064-2068. DOI: 10.1080/14767058.2018.1538348 . https://www.ncbi.nlm.nih.gov/pubmed/30332903

[51]	Iyengar H, Kumar P, Kumar P. Pulse-oximetry screening to detect critical congenital heart disease in the neonatal intensive care unit[J]. Pediatr Cardiol, 2014, 35(3): 406-410. DOI: 10.1007/s00246-013-0793-2 . https://www.ncbi.nlm.nih.gov/pubmed/24026810

[52]	Ngeow AJ, Tan MG, Choo JT, et al. Screening for congenital heart disease in a Singapore neonatal unit[J]. Singapore Med J, 2021, 62(7): 341-346. PMCID: PMC8801843. DOI: 10.11622/smedj.2019167 . https://www.ncbi.nlm.nih.gov/pubmed/31820009

[53]	Lannering K, Kazamia K, Bergman G, et al. Screening for critical congenital heart defects in Sweden[J]. Pediatrics, 2023, 152(4): e2023061949. DOI: 10.1542/peds.2023-061949 . https://www.ncbi.nlm.nih.gov/pubmed/37732389

[54]

Marcus BS, Perez-Kersey P, Lee AB, et al. The performance of critical congenital heart disease screening in rural versus urban locations in the northwest United States[J]. J Pediatr Clin Pract, 2024, 14: 200120. PMCID: PMC11417331. DOI: 10.1016/j.jpedcp.2024.200120 . https://www.ncbi.nlm.nih.gov/pubmed/39314999 本文引用 [1]

[55]

Gopalakrishnan S, Karmani S, Pandey A, et al. Pulse oximetry screening to detect critical congenital heart diseases in asymptomatic neonates[J]. Med J Armed Forces India, 2021, 77(2): 214-219. PMCID: PMC8042503. DOI: 10.1016/j.mjafi.2020.09.004 . https://www.ncbi.nlm.nih.gov/pubmed/33867640 本文引用 [1]

[56]	Zuppa AA, Riccardi R, Catenazzi P, et al. Clinical examination and pulse oximetry as screening for congenital heart disease in low-risk newborn[J]. J Matern Fetal Neonatal Med, 2015, 28(1): 7-11. DOI: 10.3109/14767058.2014.899573 . https://www.ncbi.nlm.nih.gov/pubmed/24588079 本文引用 [1]

[57]	Mohsin M, Humayun KN, Atiq M. Clinical screening for congenital heart disease in newborns at a tertiary care hospital of a developing country[J]. Cureus, 2019, 11(6): e4808. PMCID: PMC6682379. DOI: 10.7759/cureus.4808 . https://www.ncbi.nlm.nih.gov/pubmed/31403007

[58]	Huang Y, Zhong S, Zhang X, et al. Large scale application of pulse oximeter and auscultation in screening of neonatal congenital heart disease[J]. BMC Pediatr, 2022, 22(1): 483. PMCID: PMC9373434. DOI: 10.1186/s12887-022-03540-7 . https://www.ncbi.nlm.nih.gov/pubmed/35962379

[59]	Boelke KL, Hokanson JS. Blood pressure screening for critical congenital heart disease in neonates[J]. Pediatr Cardiol, 2014, 35(8): 1349-1355. DOI: 10.1007/s00246-014-0935-1 . https://www.ncbi.nlm.nih.gov/pubmed/24898292 本文引用 [1]

[60]	Izhar FM, Abqari S, Shahab T, et al. Clinical score to detect congenital heart defects: concept of second screening[J]. Ann Pediatr Cardiol, 2020, 13(4): 281-288. PMCID: PMC7727906. DOI: 10.4103/apc.APC_113_19 . https://www.ncbi.nlm.nih.gov/pubmed/33311915 本文引用 [1]

[61]

Gaonkar PM, Mutha SR, Sanghani IM. Enhancing neonatal care: the vital role of pulse oximetry in the early screening of critical congenital heart diseases and respiratory diseases in rural areas[J]. Cureus, 2024, 16(4): e58398. PMCID: PMC11097288. DOI: 10.7759/cureus.58398 . https://www.ncbi.nlm.nih.gov/pubmed/38756257

[62]	Siefkes H, Kair L, Tancredi DJ, et al. Oxygen saturation and perfusion index-based enhanced critical congenital heart disease screening[J]. Am J Perinatol, 2020, 37(2): 158-165. DOI: 10.1055/s-0039-1685445 . https://www.ncbi.nlm.nih.gov/pubmed/31003242

[63]	Rasmussen M, Suttner D, Poeltler D, et al. Use of pulse oximetry pulsatility index screening for critical congenital heart disease[J]. Am J Perinatol, 2024, 41(S 01): e545-e549. DOI: 10.1055/a-1904-9389 . https://www.ncbi.nlm.nih.gov/pubmed/35858650

[64]	花玮, 黄国英, 胡晓静. 外周灌注指数在新生儿先天性心脏病筛查中的应用[J]. 中国小儿急救医学, 2022, 29(11): 901-906. DOI: 10.3760/cma.j.issn.1673-4912.2022.11.010 . 本文引用 [1]

[65]	Wright J, Kohn M, Niermeyer S, et al. Feasibility of critical congenital heart disease newborn screening at moderate altitude[J]. Pediatrics, 2014, 133(3): e561-e569. DOI: 10.1542/peds.2013-3284 . https://www.ncbi.nlm.nih.gov/pubmed/24567022 本文引用 [1]

[66]

Sneeringer MR, Vadlaputi P, Lakshminrusimha S, et al. Lower pass threshold (≥93%) for critical congenital heart disease screening at high altitude prevents repeat screening and reduces false positives[J]. J Perinatol, 2022, 42(9): 1176-1182. PMCID: PMC9436775. DOI: 10.1038/s41372-022-01491-6 . https://www.ncbi.nlm.nih.gov/pubmed/35978107

[67]

Dilli D, Doğan V, Özyurt BM, et al. Should we start a nationwide screening program for critical congenital heart disease in Turkey? A pilot study on four centres with different altitudes[J]. Cardiol Young, 2019, 29(4): 475-480. DOI: 10.1017/S1047951119000052 . https://www.ncbi.nlm.nih.gov/pubmed/30957737 本文引用 [2]

[68]	国家卫生健康委. 新生儿先天性心脏病筛查项目工作方案: 国卫妇幼儿卫便函[2018]68号[EB/OL].(2018-07-31)[2025-05-03]. https://www.nhc.gov.cn/fys/c100077/201807/279675f44d3b40c5810a82007420e947.shtml 本文引用 [2]

[69]	上海市卫生健康委员会. 关于印发上海市新生儿先天性心脏病筛查技术方案（2022版）的通知: 沪卫妇幼〔2022〕6号[EB/OL]. (2022-02-22)[2025-05-03]. https://wsjkw.sh.gov.cn/fybj2/20220222/6943fbdfbbfa4404866d6666c368706f.html 本文引用 [1]

[70]	Singh Y, Lakshminrusimha S. Perinatal cardiovascular physiology and recognition of critical congenital heart defects[J]. Clin Perinatol, 2021, 48(3): 573-594. DOI: 10.1016/j.clp.2021.05.008 . https://www.ncbi.nlm.nih.gov/pubmed/34353581 本文引用 [1]

[71]

Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography[J]. J Am Coll Cardiol, 2014, 64(19): 2039-2060. DOI: 10.1016/j.jacc.2014.08.003 . https://www.ncbi.nlm.nih.gov/pubmed/25277848 本文引用 [1]